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Background. Health data personally collected by individuals with wearable devices and smartphones is becoming an important
data source for healthcare, but also for medical research. Objective. To describe a new consent model that allows people to control
their personally collected health data and determine to what extent they want to share these for research purposes. Methods. We
developed, in close collaboration with patients, researchers, healthcare professionals, privacy experts, and an accredited Medical
Ethical Review Committee, an innovative concept called “personalized consent flow” within a research platform connected to a
personal health record. The development was an iterative process with informal meetings, semistructured interviews, and surveys.
The final concept of the personalized consent flow was reviewed by patients and improved and approved by the same patients in a
focus group. Results. This concept could result in optimal control for individual users, since they will answer questions about how
they will share data. Furthermore, it enables users to collect data for specific studies and add expiration dates to their data. This
work facilitates further discussion about dynamic and personalized consent. A pilot study with the personalized consent model is
currently being carried out.
1. Introduction
A growing number of individuals use smartphones, tablets,
and other wearable devices to measure health parame-
ters, symptoms, and lifestyle factors. This development will
influence healthcare and the way medical research will
be conducted. Particularly, advanced sensing devices in
combination with mobile Internet and cloud storage pro-
duce a continuous stream of data, probably resulting in
earlier detection of clinical deterioration or recovery and
improved performance of prediction models. Although the
possibilities of using these data for medical research are
promising, privacy and security issues remain challenging
[1], especially for wearable devices [2]. Furthermore, there
is a need for new consent models since consumers will be
in control of their data, instead of researchers or physi-
cians.
2. Self-Collected Data for Health Research
The potential benefits of using self-collected health data
for healthcare and research in particular seem widespread.
Last year, Apple introduced “ResearchKit,” an online tool
to collect health data for medical research. It showed that
efficient patient recruitment for medical studies in a short
timeframe is possible: in a few hours 7,000 participants
were recruited for a Parkinson study whereas the largest
comparable study consisted of 1,700 subjects and recruitment
tookmore than one year. Another example is PatientsLikeMe:
an online platform on which 300,000 patients track their
health and connect with other people having the same
disease. Moreover, PatientsLikeMe users can donate their
data for research and PatientsLikeMe launched the platform
“Open Research Exchange” aiming to create health outcome
measurements.
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Although people seem willing to share their (self-
collected) health data for the “general good” in order to
contribute to research and new insights [3, 4], consenting
only once for several (future) research purposes, which is
also current practice for PatientsLikeMe and studies using
ResearchKit, is not putting consumers in control of their data.
Therefore, dynamic consent models comparable to those for
biobank projects could be an acceptable solution to deal with
this issue [5].This allows consumers to share data for specific
research projects and for a specific period of time. Although
consumers can easily change their preferences, the data col-
lection is still static: it does not take into account continuous
data collection and donation by one subject. Meta consent
models have been proposed for use of secondary health data
[6], but these do not meet contemporary characteristics of
continuously collected health data and data controlled in
personal health records (PHR) either. In theUK, the care.data
program is currently being implemented, which enhances
disclosure of medical data for research by an opt-out system.
Due to scarce communication and explanation, this opt-out
system is still part of an on-going debate, with concerns about
the private sector having access to merged health data [7].
These three examples show that it is challenging to implement
a consent system that covers all aspects related to using self-
collected health data for medical research.
3. Personalized Consent Flow
Therefore, we propose an innovative concept called “person-
alized consent flow” together with a research platform con-
nected to a PHR to meet all characteristics of contemporary
data collection and data sharing. Using this platform named
“Here is my data” (HIMD), researchers can collaborate with
users. This ensures that users have full control of their
data and are able to share these for scientific research. This
concept was developed in close collaboration with patients,
the patient advisory board from a large academic hospital,
the Dutch Patient Federation, researchers, healthcare profes-
sionals, privacy experts, and an accredited Medical Ethical
Review Committee. It was an iterative process with informal
meetings, semistructured interviews, and surveys. First, we
performed a gap-fit analysis to structure the problem and
identify the gaps between current methods of research with
traditionally collected data compared to using self-collected
health data with HIMD. A gap-fit analysis is a technique
used to determine what steps are needed to move from a
current state to a desired future state [8]. The gaps were
identified based on analysis of relevant literature, regula-
tions, laws, and reports. Second, semistructured interviews
with incorporated stakeholders were conducted to obtain
information about their opinions, needs, and stakes of the
incorporated stakeholders. An interview guide, based on
the human, organization, and technology-FIT framework
was used [9]. The following themes were discussed: human
factors, organizational factors, and technology factors, in
relation to HIMD as a research platform. Furthermore, addi-
tional themes that emerged during the interview were also
further discussed. The interviews were transcribed and over-
arching themes were identified by one author (Ester A. Rake)
and discussed with a second author (Tom H. van de Belt)
with expertise in qualitative research. These two information
sources lead to identification of the fits and gaps related to
ethics and regulations and the current situation regarding
medical ethical research committees, consent, and research
compared to the future situation using the research platform
of HIMD. Third, we discussed hypothetical research casus
using HIMD-data and possible consent choices for HIMD
users with the Medical Ethical Review Committee, to learn
more about the acceptability of different options. Moreover,
options for future use of HIMD-data for research were iden-
tified and discussed with relevant stakeholders. This resulted
in several concept versions of the personalized consent flow,
of which the final version was reviewed by patients and
improved and approved by the same patients in a focus
group.Moreover, theMedical Ethical ReviewCommittee also
reviewed and approved the draft version of the personalized
consent flow.
In this collaboration we determined that the consent flow
should be personalized, transparent, and very simple. This
could result in optimal control for individual PHR users and
may increase trust among users [10]. Therefore, three main
features characterize the proposed consent flow (Figure 1).
First, users are asked general questions about sharing data.
When they wish to share data for scientific research, theymay
opt for “narrow” consent, which implies that their consent
will be asked for every individual study for which their data is
of interest, or “broad” consent, which can be used formultiple
studies. Furthermore, users are able to decide which data will
be shared for specific studies and with whom. Logically, users
receive similar questions when they add new data sources to
their PHR, such as wearable devices. This principle is similar
to changing privacy settings on Facebook. Second, users
can choose to share existing data that they have collected
passively, to share prospectively, collect data, or both. For
prospective studies, researchers can invite specific users to
collect selected data during a specific time period (e.g., heart
rate with a wearable for the next two weeks), which is called
a “research request” for active data collection.This is possible
since the system allows them to identify potential study
participants anonymously, based on their consent choices.
Users can also be notified about future studies by signing
up for the research program, which was already proposed
by Mandl and Kohane in 2008 [11]. Third, expiration dates
are connected to each consent choice, which ensures that a
user reconsiders his decision. A default expiration date of
one year will be assigned, but users may also select personal
expiration dates, such as an expiration date connected to
the duration of the study. Obviously, users can quit sharing
data at any time. During all steps, users are informed about
implications of consent options by using innovative consent
tools such as videos, information graphics, and appealing
examples. This ensures that users know what they consented
for, in contrast withmany existing platforms that have lengthy
terms and conditions that discourage users from reading,
who subsequently sign an uninformed consent.
Although we feel that the personalized consent flow
would result in a novel participatory research design in
which self-collected data is efficiently used and shared, some
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Figure 1: Outline of the personalized consent flow.
challenges exist. First, it is challenging to create the technical
design that meets all necessary characteristics. Second, the
design should efficiently deal with inactive users. Finally,
user empowerment potentially jeopardizes the creation of
optimal data sets since users can quit whenever they want.
Therefore, an optimal balance between user empowerment
and commitment has to be found.
4. Conclusion
Personally collected health data will become an important
data source for medical research. New consent models are
urgently needed to allow people to control their personally
collected health data and determine to what extent they
want to share these for research purposes. The personalized
consent flow proposed could serve as a starting point to
meet all requirements for sharing personally collected and
controlled health data for research. This work facilitates fur-
ther discussion about dynamic and personalized consent. A
pilot study with the personalized consent model is currently
being carried out.
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